Defect in debilitating neurodegenerative disease reversed in mouse nerves
Scientists from the School of Medicine have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet and legs.
Using tooth sensors to detect disease
An interdisciplinary team of researchers from the School of Medicine and the School of Engineering & Applied Science is redefining the notion of a wisdom tooth. The team is developing technology that could someday be used to detect early signs of certain diseases in high-risk patients.
Psoriasis treated with compound derived from immune cells
A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from the School of Medicine.
Brain scans may help diagnose neurological, psychiatric disorders
A new School of Medicine study shows that a kind of brain scan called functional connectivity MRI (fcMRI) – which shows how brain regions interact – can reliably detect fundamental differences in how individual brains are wired.
Achilefu, Elgin to receive 2018 faculty achievement awards
Sarah C.R. Elgin and Samuel I. Achilefu will receive Washington University in St. Louis’ 2018 faculty achievement awards, Chancellor Mark S. Wrighton announced. Also, William A. Frazier III, professor emeritus, will be honored for innovation and entrepreneurship.
New clues point to relief for chronic itching
Studying mice, School of Medicine researchers found that a drug can deliver itch relief by targeting particular opioid receptors on neurons in the spinal cord. The drug is being tested for its anti-itch effects in the U.S., but until now scientists haven’t understood how it works.
Text messaging tool may help fight opioid epidemic
A new automated text messaging service may curb opioid abuse and reduce the likelihood of relapse while also decreasing treatment costs, according to researchers at Washington University School of Medicine and Epharmix, a St. Louis-based digital health company.
Cooper named director of center for primary immunodeficiencies
Megan Cooper, MD, PhD, assistant professor of pediatrics and of pathology and immunology at Washington University School of Medicine in St. Louis, has been named director of the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at St. Louis Children’s Hospital.
How highly contagious norovirus infection gets its start
Researchers at the School of Medicine have identified how the highly contagious norovirus infection begins, in mice. Norovirus is a major cause of gastrointestinal illness worldwide.
Pancreas SPORE program applications due May 15
Applications for the Pancreas SPORE Developmental Research Award, Disparities Developmental Research Award and Career Enhancement Awards are being accepted through May 15. The award supports innovative translational pancreas research and provides up to $75,000 for a year.
View More Stories